PFE Stock: Pfizer Inc. Stock Price, Analysis & Insights
Get live pfe stock price $24.65, comprehensive Pfizer Inc. stock analysis, charts, news, and expert forecast. Real-time pfe stock data and investment insights.
Loading chart...
Company Overview
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Company Information
- CEO
- Albert Bourla
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 81000
Contact Information
- Website
- https://www.pfizer.com
- Address
- 235 East 42nd Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 140.1 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 13.0)
✓ Lower volatility stock (Beta: 0.47) may provide portfolio stability
Business Model & Strategy
Pfizer Inc. operates in the Drug Manufacturers - General industry, focusing on medical services, pharmaceutical development, and healthcare delivery. As a mid-cap company, Pfizer Inc. benefits from scale advantages, market presence, and established operations. Under the leadership of CEO Albert Bourla, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - General model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Pfizer Inc. competes in the Drug Manufacturers - General within the broader Healthcare. With 140.1 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Pfizer Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Pfizer Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Pfizer Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Pfizer Inc.
- ⚠Investors should consider how Pfizer Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
140.15B
P/E Ratio
13.04
Beta
0.47
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 140.15B market capitalization
- Trading Volume: 132.56M shares traded today
- Price Range: 52-week range of $20.92 - $28.14
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Pfizer Inc.
Pfizer Inc. (PFE) operates in the Drug Manufacturers - General industry within the Healthcare sector. With a current market capitalization of 140.15B, the company represents a significant player in its market. The stock is currently trading at $24.65 with a positivedaily change of 1.48%.
The company's 81000 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 13.04, beta of 0.47, and 52-week price range from $20.92 to $28.14when evaluating investment opportunities.
Why Invest in Pfizer Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Albert Bourla
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.